date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.01428.
Step length converged once. Increasing MCMC sample size.
Iteration 2 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.0113.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       4       19     1281     1041      833      336      373      325 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     303      210      115       86       36       26        9        3 
1 
disease_progression 
H-positive risk:  847 881 119 887 432 136 912 452 96 58 116 64 
H-negative risk:  881 847 912 887 452 432 136 119 116 96 64 58 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 2 

clinical_engagement 
diagnosis 
demography 
58 new agents 
2 
disease_progression 
H-positive risk:  850 882 120 884 437 135 907 451 96 58 117 63 
H-negative risk:  882 850 907 884 451 437 135 120 117 96 63 58 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 3 

clinical_engagement 
diagnosis 
demography 
45 new agents 
3 
disease_progression 
H-positive risk:  857 877 121 885 428 134 917 449 96 57 117 62 
H-negative risk:  877 857 917 885 449 428 134 121 117 96 62 57 
New BC onsets:  4
BC status:  4996 4 
BC subtype:  4996 4 

clinical_engagement 
diagnosis 
demography 
56 new agents 
4 
disease_progression 
H-positive risk:  860 882 119 884 429 135 916 445 98 56 114 62 
H-negative risk:  882 860 916 884 445 429 135 119 114 98 62 56 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 5 

clinical_engagement 
diagnosis 
demography 
63 new agents 
5 
disease_progression 
H-positive risk:  865 891 120 889 421 137 915 431 97 54 114 66 
H-negative risk:  891 865 915 889 431 421 137 120 114 97 66 54 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 5 

clinical_engagement 
diagnosis 
demography 
58 new agents 
6 
disease_progression 
H-positive risk:  873 895 122 890 418 137 906 423 100 53 116 67 
H-negative risk:  895 873 906 890 423 418 137 122 116 100 67 53 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 5 

clinical_engagement 
diagnosis 
demography 
68 new agents 
7 
disease_progression 
H-positive risk:  878 906 122 892 409 136 903 418 101 53 115 67 
H-negative risk:  906 878 903 892 418 409 136 122 115 101 67 53 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 4 1 

clinical_engagement 
diagnosis 
demography 
57 new agents 
8 
disease_progression 
H-positive risk:  884 910 122 882 412 139 900 415 101 53 115 67 
H-negative risk:  910 884 900 882 415 412 139 122 115 101 67 53 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 5 2 

clinical_engagement 
diagnosis 
demography 
61 new agents 
9 
disease_progression 
H-positive risk:  882 920 123 877 409 139 896 418 101 54 114 67 
H-negative risk:  920 882 896 877 418 409 139 123 114 101 67 54 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 9 3 

clinical_engagement 
diagnosis 
demography 
43 new agents 
10 
disease_progression 
H-positive risk:  880 927 123 878 407 140 890 416 103 53 115 68 
H-negative risk:  927 880 890 878 416 407 140 123 115 103 68 53 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 8 4 

clinical_engagement 
diagnosis 
demography 
59 new agents 
11 
disease_progression 
H-positive risk:  886 933 122 876 408 141 883 414 102 50 117 68 
H-negative risk:  933 886 883 876 414 408 141 122 117 102 68 50 
New BC onsets:  15
BC status:  4985 15 
BC subtype:  4985 11 4 

clinical_engagement 
diagnosis 
demography 
69 new agents 
12 
disease_progression 
H-positive risk:  887 935 123 870 397 143 897 408 104 50 118 68 
H-negative risk:  935 887 897 870 408 397 143 123 118 104 68 50 
New BC onsets:  15
BC status:  4985 15 
BC subtype:  4985 11 4 

clinical_engagement 
diagnosis 
demography 
69 new agents 
13 
disease_progression 
H-positive risk:  824 873 115 926 387 131 965 411 117 50 131 70 
H-negative risk:  873 824 965 926 411 387 131 115 131 117 70 50 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 11 5 

clinical_engagement 
diagnosis 
demography 
221 new agents 
14 
disease_progression 
H-positive risk:  854 901 123 880 412 137 910 425 109 52 120 77 
H-negative risk:  901 854 910 880 425 412 137 123 120 109 77 52 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 14 5 

clinical_engagement 
diagnosis 
demography 
51 new agents 
15 
disease_progression 
H-positive risk:  859 909 124 882 409 138 908 418 106 53 118 76 
H-negative risk:  909 859 908 882 418 409 138 124 118 106 76 53 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 14 6 

clinical_engagement 
diagnosis 
demography 
68 new agents 
16 
disease_progression 
H-positive risk:  857 913 123 886 404 139 907 421 105 53 119 73 
H-negative risk:  913 857 907 886 421 404 139 123 119 105 73 53 
New BC onsets:  21
BC status:  4979 21 
BC subtype:  4979 15 6 

clinical_engagement 
diagnosis 
demography 
55 new agents 
17 
disease_progression 
H-positive risk:  860 917 124 883 403 138 906 419 105 52 119 74 
H-negative risk:  917 860 906 883 419 403 138 124 119 105 74 52 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 13 6 

clinical_engagement 
diagnosis 
demography 
67 new agents 
18 
disease_progression 
H-positive risk:  866 926 124 882 402 141 899 412 106 49 119 74 
H-negative risk:  926 866 899 882 412 402 141 124 119 106 74 49 
New BC onsets:  21
BC status:  4979 21 
BC subtype:  4979 15 6 

clinical_engagement 
diagnosis 
demography 
63 new agents 
19 
disease_progression 
H-positive risk:  870 930 126 881 403 143 897 408 106 47 117 72 
H-negative risk:  930 870 897 881 408 403 143 126 117 106 72 47 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 15 7 

clinical_engagement 
diagnosis 
demography 
56 new agents 
20 
disease_progression 
H-positive risk:  872 925 126 880 402 143 899 409 106 52 116 70 
H-negative risk:  925 872 899 880 409 402 143 126 116 106 70 52 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 16 6 

clinical_engagement 
diagnosis 
demography 
65 new agents 
21 
disease_progression 
H-positive risk:  880 929 129 876 393 142 906 404 107 52 114 68 
H-negative risk:  929 880 906 876 404 393 142 129 114 107 68 52 
New BC onsets:  23
BC status:  4977 23 
BC subtype:  4977 16 7 

clinical_engagement 
diagnosis 
demography 
62 new agents 
22 
disease_progression 
H-positive risk:  888 937 130 871 394 140 904 400 106 46 115 69 
H-negative risk:  937 888 904 871 400 394 140 130 115 106 69 46 
New BC onsets:  23
BC status:  4977 23 
BC subtype:  4977 16 7 

clinical_engagement 
diagnosis 
demography 
59 new agents 
23 
disease_progression 
H-positive risk:  883 940 132 869 392 140 909 392 109 50 115 69 
H-negative risk:  940 883 909 869 392 392 140 132 115 109 69 50 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 17 7 

clinical_engagement 
diagnosis 
demography 
51 new agents 
24 
disease_progression 
H-positive risk:  888 932 131 872 391 140 913 389 108 50 117 69 
H-negative risk:  932 888 913 872 389 391 140 131 117 108 69 50 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 17 7 

clinical_engagement 
diagnosis 
demography 
62 new agents 
25 
disease_progression 
H-positive risk:  815 864 121 949 389 129 985 387 117 51 124 69 
H-negative risk:  864 815 985 949 387 389 129 121 124 117 69 51 
New BC onsets:  26
BC status:  4974 26 
BC subtype:  4974 19 7 

clinical_engagement 
diagnosis 
demography 
171 new agents 
26 
disease_progression 
H-positive risk:  830 886 122 909 412 134 941 417 110 54 115 70 
H-negative risk:  886 830 941 909 417 412 134 122 115 110 70 54 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 24 7 

clinical_engagement 
diagnosis 
demography 
58 new agents 
27 
disease_progression 
H-positive risk:  829 890 124 900 415 136 940 416 110 55 113 72 
H-negative risk:  890 829 940 900 416 415 136 124 113 110 72 55 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 27 6 

clinical_engagement 
diagnosis 
demography 
60 new agents 
28 
disease_progression 
H-positive risk:  834 891 127 903 408 137 940 411 110 56 113 70 
H-negative risk:  891 834 940 903 411 408 137 127 113 110 70 56 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 26 6 

clinical_engagement 
diagnosis 
demography 
78 new agents 
29 
disease_progression 
H-positive risk:  842 898 126 908 398 137 935 409 106 58 114 69 
H-negative risk:  898 842 935 908 409 398 137 126 114 106 69 58 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 26 6 

clinical_engagement 
diagnosis 
demography 
65 new agents 
30 
disease_progression 
H-positive risk:  842 903 127 907 399 140 925 406 106 60 116 69 
H-negative risk:  903 842 925 907 406 399 140 127 116 106 69 60 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 27 6 

clinical_engagement 
diagnosis 
demography 
56 new agents 
31 
disease_progression 
H-positive risk:  841 904 127 904 401 142 923 408 103 60 119 68 
H-negative risk:  904 841 923 904 408 401 142 127 119 103 68 60 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 30 6 

clinical_engagement 
diagnosis 
demography 
67 new agents 
32 
disease_progression 
H-positive risk:  841 902 126 904 401 143 927 403 105 60 121 67 
H-negative risk:  902 841 927 904 403 401 143 126 121 105 67 60 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 29 8 

clinical_engagement 
diagnosis 
demography 
62 new agents 
33 
disease_progression 
H-positive risk:  847 904 126 901 395 142 933 407 103 57 120 65 
H-negative risk:  904 847 933 901 407 395 142 126 120 103 65 57 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 31 8 

clinical_engagement 
diagnosis 
demography 
68 new agents 
34 
disease_progression 
H-positive risk:  844 912 124 902 390 141 942 401 103 57 120 64 
H-negative risk:  912 844 942 902 401 390 141 124 120 103 64 57 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 32 9 

clinical_engagement 
diagnosis 
demography 
60 new agents 
35 
disease_progression 
H-positive risk:  841 915 124 905 381 142 943 403 104 58 120 64 
H-negative risk:  915 841 943 905 403 381 142 124 120 104 64 58 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 33 10 

clinical_engagement 
diagnosis 
demography 
57 new agents 
36 
disease_progression 
H-positive risk:  843 915 124 910 382 142 934 401 104 57 124 64 
H-negative risk:  915 843 934 910 401 382 142 124 124 104 64 57 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 34 10 

clinical_engagement 
diagnosis 
demography 
55 new agents 
37 
disease_progression 
H-positive risk:  779 860 116 971 381 128 1006 390 117 55 134 63 
H-negative risk:  860 779 1006 971 390 381 128 116 134 117 63 55 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 35 10 

clinical_engagement 
diagnosis 
demography 
145 new agents 
38 
disease_progression 
H-positive risk:  796 874 118 942 407 133 964 412 115 49 124 66 
H-negative risk:  874 796 964 942 412 407 133 118 124 115 66 49 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 37 9 

clinical_engagement 
diagnosis 
demography 
83 new agents 
39 
disease_progression 
H-positive risk:  797 888 124 934 396 133 961 408 117 48 125 69 
H-negative risk:  888 797 961 934 408 396 133 124 125 117 69 48 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 38 9 

clinical_engagement 
diagnosis 
demography 
75 new agents 
40 
disease_progression 
H-positive risk:  800 888 125 941 391 133 955 409 117 47 125 69 
H-negative risk:  888 800 955 941 409 391 133 125 125 117 69 47 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 37 9 

clinical_engagement 
diagnosis 
demography 
58 new agents 
41 
disease_progression 
H-positive risk:  806 891 125 939 390 130 946 412 119 48 124 70 
H-negative risk:  891 806 946 939 412 390 130 125 124 119 70 48 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 37 10 

clinical_engagement 
diagnosis 
demography 
71 new agents 
42 
disease_progression 
H-positive risk:  806 890 127 938 390 127 948 415 120 50 123 66 
H-negative risk:  890 806 948 938 415 390 127 127 123 120 66 50 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 40 11 

clinical_engagement 
diagnosis 
demography 
70 new agents 
43 
disease_progression 
H-positive risk:  809 895 125 936 385 128 941 418 123 50 123 67 
H-negative risk:  895 809 941 936 418 385 128 125 123 123 67 50 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 42 11 

clinical_engagement 
diagnosis 
demography 
61 new agents 
44 
disease_progression 
H-positive risk:  814 901 125 935 384 129 943 412 122 47 123 65 
H-negative risk:  901 814 943 935 412 384 129 125 123 122 65 47 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 44 10 

clinical_engagement 
diagnosis 
demography 
63 new agents 
45 
disease_progression 
H-positive risk:  820 906 125 932 384 129 940 407 123 46 125 63 
H-negative risk:  906 820 940 932 407 384 129 125 125 123 63 46 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 45 10 

clinical_engagement 
diagnosis 
demography 
72 new agents 
46 
disease_progression 
H-positive risk:  829 910 125 933 385 130 934 401 123 45 125 60 
H-negative risk:  910 829 934 933 401 385 130 125 125 123 60 45 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 44 11 

clinical_engagement 
diagnosis 
demography 
80 new agents 
47 
disease_progression 
H-positive risk:  838 918 130 936 373 130 927 396 121 48 123 60 
H-negative risk:  918 838 927 936 396 373 130 130 123 121 60 48 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 42 11 

clinical_engagement 
diagnosis 
demography 
55 new agents 
48 
disease_progression 
H-positive risk:  839 919 130 936 369 132 926 397 120 48 124 60 
H-negative risk:  919 839 926 936 397 369 132 130 124 120 60 48 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 41 12 

clinical_engagement 
diagnosis 
demography 
72 new agents 
49 
disease_progression 
H-positive risk:  778 855 118 1001 360 124 998 398 130 48 131 59 
H-negative risk:  855 778 998 1001 398 360 124 118 131 130 59 48 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 40 13 

clinical_engagement 
diagnosis 
demography 
141 new agents 
50 
disease_progression 
H-positive risk:  804 858 118 984 373 124 988 392 124 47 127 61 
H-negative risk:  858 804 988 984 392 373 124 118 127 124 61 47 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 42 14 

clinical_engagement 
diagnosis 
demography 
86 new agents 
51 
disease_progression 
H-positive risk:  809 871 118 980 366 126 980 388 124 47 133 58 
H-negative risk:  871 809 980 980 388 366 126 118 133 124 58 47 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 44 14 

clinical_engagement 
diagnosis 
demography 
62 new agents 
52 
disease_progression 
H-positive risk:  810 870 117 987 360 126 986 379 124 47 136 58 
H-negative risk:  870 810 986 987 379 360 126 117 136 124 58 47 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 46 15 

clinical_engagement 
diagnosis 
demography 
67 new agents 
53 
disease_progression 
H-positive risk:  806 867 118 986 365 127 990 373 124 48 138 58 
H-negative risk:  867 806 990 986 373 365 127 118 138 124 58 48 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 46 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
54 
disease_progression 
H-positive risk:  810 869 120 983 360 129 986 374 125 49 137 58 
H-negative risk:  869 810 986 983 374 360 129 120 137 125 58 49 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 47 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
55 
disease_progression 
H-positive risk:  816 866 118 979 356 129 991 370 129 49 140 57 
H-negative risk:  866 816 991 979 370 356 129 118 140 129 57 49 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 49 18 

clinical_engagement 
diagnosis 
demography 
66 new agents 
56 
disease_progression 
H-positive risk:  823 865 120 980 355 123 989 368 133 47 142 55 
H-negative risk:  865 823 989 980 368 355 123 120 142 133 55 47 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 53 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
57 
disease_progression 
H-positive risk:  826 867 121 984 348 124 987 366 136 46 139 56 
H-negative risk:  867 826 987 984 366 348 124 121 139 136 56 46 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 57 17 

clinical_engagement 
diagnosis 
demography 
79 new agents 
58 
disease_progression 
H-positive risk:  825 872 121 976 352 124 989 362 136 48 141 54 
H-negative risk:  872 825 989 976 362 352 124 121 141 136 54 48 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 60 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
59 
disease_progression 
H-positive risk:  831 873 121 983 356 125 984 351 136 47 142 51 
H-negative risk:  873 831 984 983 351 356 125 121 142 136 51 47 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 59 17 

clinical_engagement 
diagnosis 
demography 
45 new agents 
60 
disease_progression 
H-positive risk:  833 868 121 989 361 123 984 347 135 46 141 52 
H-negative risk:  868 833 984 989 347 361 123 121 141 135 52 46 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 60 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
61 
disease_progression 
H-positive risk:  787 814 116 1051 354 119 1039 344 138 44 144 50 
H-negative risk:  814 787 1039 1051 344 354 119 116 144 138 50 44 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 63 17 

clinical_engagement 
diagnosis 
demography 
115 new agents 
62 
disease_progression 
H-positive risk:  785 827 116 1047 366 117 999 376 138 42 136 51 
H-negative risk:  827 785 999 1047 376 366 117 116 136 138 51 42 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 64 17 

clinical_engagement 
diagnosis 
demography 
75 new agents 
63 
disease_progression 
H-positive risk:  792 826 118 1043 367 117 991 376 140 43 137 50 
H-negative risk:  826 792 991 1043 376 367 117 118 137 140 50 43 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 66 17 

clinical_engagement 
diagnosis 
demography 
63 new agents 
64 
disease_progression 
H-positive risk:  794 829 116 1040 371 117 992 371 141 43 136 50 
H-negative risk:  829 794 992 1040 371 371 117 116 136 141 50 43 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 65 17 

clinical_engagement 
diagnosis 
demography 
59 new agents 
65 
disease_progression 
H-positive risk:  797 825 118 1038 365 119 999 371 140 41 138 49 
H-negative risk:  825 797 999 1038 371 365 119 118 138 140 49 41 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 66 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
66 
disease_progression 
H-positive risk:  798 826 118 1030 367 116 998 374 141 43 139 50 
H-negative risk:  826 798 998 1030 374 367 116 118 139 141 50 43 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
63 new agents 
67 
disease_progression 
H-positive risk:  803 824 118 1032 361 118 995 378 144 41 136 50 
H-negative risk:  824 803 995 1032 378 361 118 118 136 144 50 41 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
47 new agents 
68 
disease_progression 
H-positive risk:  811 824 120 1032 359 118 990 377 145 40 134 50 
H-negative risk:  824 811 990 1032 377 359 118 120 134 145 50 40 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
69 
disease_progression 
H-positive risk:  815 819 119 1037 359 117 988 379 142 41 138 46 
H-negative risk:  819 815 988 1037 379 359 117 119 138 142 46 41 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 70 19 

clinical_engagement 
diagnosis 
demography 
64 new agents 
70 
disease_progression 
H-positive risk:  816 821 121 1035 362 115 981 381 141 43 138 46 
H-negative risk:  821 816 981 1035 381 362 115 121 138 141 46 43 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
62 new agents 
71 
disease_progression 
H-positive risk:  817 815 118 1044 364 115 979 378 143 41 141 45 
H-negative risk:  815 817 979 1044 378 364 115 118 141 143 45 41 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 75 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
72 
disease_progression 
H-positive risk:  819 822 118 1035 366 116 979 372 147 39 142 45 
H-negative risk:  822 819 979 1035 372 366 116 118 142 147 45 39 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 74 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
73 
disease_progression 
H-positive risk:  771 772 110 1088 365 105 1033 370 155 35 151 45 
H-negative risk:  772 771 1033 1088 370 365 105 110 151 155 45 35 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 75 17 

clinical_engagement 
diagnosis 
demography 
109 new agents 
74 
disease_progression 
H-positive risk:  764 785 110 1062 385 108 1030 378 150 37 150 41 
H-negative risk:  785 764 1030 1062 378 385 108 110 150 150 41 37 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 75 17 

clinical_engagement 
diagnosis 
demography 
75 new agents 
75 
disease_progression 
H-positive risk:  761 786 110 1070 387 109 1020 384 148 38 149 38 
H-negative risk:  786 761 1020 1070 384 387 109 110 149 148 38 38 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 77 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
76 
disease_progression 
H-positive risk:  762 788 111 1073 384 104 1017 386 148 39 151 37 
H-negative risk:  788 762 1017 1073 386 384 104 111 151 148 37 39 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 82 15 

clinical_engagement 
diagnosis 
demography 
65 new agents 
77 
disease_progression 
H-positive risk:  760 797 111 1066 387 105 1017 383 144 42 148 40 
H-negative risk:  797 760 1017 1066 383 387 105 111 148 144 40 42 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 81 15 

clinical_engagement 
diagnosis 
demography 
68 new agents 
78 
disease_progression 
H-positive risk:  755 809 109 1065 387 105 1023 373 147 41 145 41 
H-negative risk:  809 755 1023 1065 373 387 105 109 145 147 41 41 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 81 15 

clinical_engagement 
diagnosis 
demography 
80 new agents 
79 
disease_progression 
H-positive risk:  761 816 109 1066 383 105 1019 372 148 42 141 38 
H-negative risk:  816 761 1019 1066 372 383 105 109 141 148 38 42 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 78 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
80 
disease_progression 
H-positive risk:  765 822 110 1067 382 105 1006 369 152 43 138 41 
H-negative risk:  822 765 1006 1067 369 382 105 110 138 152 41 43 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
81 
disease_progression 
H-positive risk:  763 824 111 1062 380 110 1005 370 151 42 138 44 
H-negative risk:  824 763 1005 1062 370 380 110 111 138 151 44 42 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
82 
disease_progression 
H-positive risk:  770 821 111 1070 374 109 997 366 156 41 140 45 
H-negative risk:  821 770 997 1070 366 374 109 111 140 156 45 41 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
83 
disease_progression 
H-positive risk:  765 825 113 1067 372 111 1003 362 156 41 141 44 
H-negative risk:  825 765 1003 1067 362 372 111 113 141 156 44 41 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
61 new agents 
84 
disease_progression 
H-positive risk:  765 828 113 1060 381 113 1002 366 154 38 138 42 
H-negative risk:  828 765 1002 1060 366 381 113 113 138 154 42 38 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
85 
disease_progression 
H-positive risk:  713 787 104 1096 380 104 1061 367 163 35 147 43 
H-negative risk:  787 713 1061 1096 367 380 104 104 147 163 43 35 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
114 new agents 
86 
disease_progression 
H-positive risk:  722 780 105 1084 396 106 1052 362 162 42 145 44 
H-negative risk:  780 722 1052 1084 362 396 106 105 145 162 44 42 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
87 
disease_progression 
H-positive risk:  729 776 105 1080 391 106 1052 368 162 41 147 43 
H-negative risk:  776 729 1052 1080 368 391 106 105 147 162 43 41 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
88 
disease_progression 
H-positive risk:  729 771 107 1090 389 106 1048 368 159 44 146 43 
H-negative risk:  771 729 1048 1090 368 389 106 107 146 159 43 44 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
89 
disease_progression 
H-positive risk:  723 776 108 1086 398 107 1044 371 159 44 142 42 
H-negative risk:  776 723 1044 1086 371 398 107 108 142 159 42 44 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
90 
disease_progression 
H-positive risk:  722 780 110 1080 399 107 1048 372 155 43 145 39 
H-negative risk:  780 722 1048 1080 372 399 107 110 145 155 39 43 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
91 
disease_progression 
H-positive risk:  727 783 111 1072 396 107 1055 365 156 44 144 40 
H-negative risk:  783 727 1055 1072 365 396 107 111 144 156 40 44 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
92 
disease_progression 
H-positive risk:  724 785 112 1076 392 106 1061 362 154 44 142 42 
H-negative risk:  785 724 1061 1076 362 392 106 112 142 154 42 44 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
93 
disease_progression 
H-positive risk:  729 789 114 1065 390 108 1059 369 155 45 139 38 
H-negative risk:  789 729 1059 1065 369 390 108 114 139 155 38 45 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
94 
disease_progression 
H-positive risk:  735 782 116 1066 385 107 1067 371 153 42 137 39 
H-negative risk:  782 735 1067 1066 371 385 107 116 137 153 39 42 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
95 
disease_progression 
H-positive risk:  738 787 117 1065 381 108 1067 371 151 40 133 42 
H-negative risk:  787 738 1067 1065 371 381 108 117 133 151 42 40 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
96 
disease_progression 
H-positive risk:  735 787 114 1066 377 108 1073 375 151 40 130 44 
H-negative risk:  787 735 1073 1066 375 377 108 114 130 151 44 40 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
97 
disease_progression 
H-positive risk:  696 738 105 1110 379 102 1114 373 156 39 144 44 
H-negative risk:  738 696 1114 1110 373 379 102 105 144 156 44 39 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 95 22 

clinical_engagement 
diagnosis 
demography 
107 new agents 
98 
disease_progression 
H-positive risk:  689 736 101 1094 401 101 1112 386 157 39 141 43 
H-negative risk:  736 689 1112 1094 386 401 101 101 141 157 43 39 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 96 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
99 
disease_progression 
H-positive risk:  684 732 101 1098 406 104 1114 382 154 39 146 40 
H-negative risk:  732 684 1114 1098 382 406 104 101 146 154 40 39 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
100 
disease_progression 
H-positive risk:  684 731 99 1097 406 101 1115 382 156 38 149 42 
H-negative risk:  731 684 1115 1097 382 406 101 99 149 156 42 38 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 98 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
101 
disease_progression 
H-positive risk:  685 729 98 1097 410 102 1113 383 153 38 150 42 
H-negative risk:  729 685 1113 1097 383 410 102 98 150 153 42 38 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 97 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
102 
disease_progression 
H-positive risk:  687 727 99 1091 407 98 1119 387 155 38 150 42 
H-negative risk:  727 687 1119 1091 387 407 98 99 150 155 42 38 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 98 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
103 
disease_progression 
H-positive risk:  685 727 99 1090 406 96 1120 391 157 37 151 41 
H-negative risk:  727 685 1120 1090 391 406 96 99 151 157 41 37 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 98 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
104 
disease_progression 
H-positive risk:  690 729 99 1091 396 99 1121 394 156 35 149 41 
H-negative risk:  729 690 1121 1091 394 396 99 99 149 156 41 35 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 97 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
105 
disease_progression 
H-positive risk:  691 731 97 1091 396 98 1116 396 156 35 151 42 
H-negative risk:  731 691 1116 1091 396 396 98 97 151 156 42 35 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 97 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
106 
disease_progression 
H-positive risk:  691 721 98 1098 401 97 1113 399 152 39 148 43 
H-negative risk:  721 691 1113 1098 399 401 97 98 148 152 43 39 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 97 19 

clinical_engagement 
diagnosis 
demography 
56 new agents 
107 
disease_progression 
H-positive risk:  691 714 100 1108 393 97 1117 400 153 38 145 44 
H-negative risk:  714 691 1117 1108 400 393 97 100 145 153 44 38 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 96 18 

clinical_engagement 
diagnosis 
demography 
59 new agents 
108 
disease_progression 
H-positive risk:  695 716 100 1102 400 98 1115 395 153 38 143 45 
H-negative risk:  716 695 1115 1102 395 400 98 100 143 153 45 38 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 97 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
109 
disease_progression 
H-positive risk:  662 684 92 1137 403 94 1148 389 158 39 150 44 
H-negative risk:  684 662 1148 1137 389 403 94 92 150 158 44 39 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 97 18 

clinical_engagement 
diagnosis 
demography 
94 new agents 
110 
disease_progression 
H-positive risk:  655 674 96 1143 408 93 1131 404 155 42 150 49 
H-negative risk:  674 655 1131 1143 404 408 93 96 150 155 49 42 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 102 18 

clinical_engagement 
diagnosis 
demography 
87 new agents 
111 
disease_progression 
H-positive risk:  664 677 97 1135 412 94 1125 406 151 42 147 50 
H-negative risk:  677 664 1125 1135 406 412 94 97 147 151 50 42 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 104 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
112 
disease_progression 
H-positive risk:  663 678 97 1134 413 93 1129 406 148 45 144 50 
H-negative risk:  678 663 1129 1134 406 413 93 97 144 148 50 45 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 105 18 

clinical_engagement 
diagnosis 
demography 
90 new agents 
113 
disease_progression 
H-positive risk:  668 669 96 1134 408 96 1132 408 151 41 145 52 
H-negative risk:  669 668 1132 1134 408 408 96 96 145 151 52 41 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 102 19 

clinical_engagement 
diagnosis 
demography 
98 new agents 
114 
disease_progression 
H-positive risk:  672 680 98 1134 402 99 1124 402 150 40 145 54 
H-negative risk:  680 672 1124 1134 402 402 99 98 145 150 54 40 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 103 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
115 
disease_progression 
H-positive risk:  671 690 98 1132 396 100 1119 405 150 38 146 55 
H-negative risk:  690 671 1119 1132 405 396 100 98 146 150 55 38 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 105 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
116 
disease_progression 
H-positive risk:  667 697 99 1132 404 104 1109 402 148 39 145 54 
H-negative risk:  697 667 1109 1132 402 404 104 99 145 148 54 39 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 106 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
117 
disease_progression 
H-positive risk:  660 693 97 1132 406 104 1110 403 149 43 147 56 
H-negative risk:  693 660 1110 1132 403 406 104 97 147 149 56 43 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 106 20 

clinical_engagement 
diagnosis 
demography 
95 new agents 
118 
disease_progression 
H-positive risk:  665 701 101 1128 398 104 1111 398 147 42 149 56 
H-negative risk:  701 665 1111 1128 398 398 104 101 149 147 56 42 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 105 18 

clinical_engagement 
diagnosis 
demography 
83 new agents 
119 
disease_progression 
H-positive risk:  677 700 99 1123 398 104 1116 388 149 40 152 54 
H-negative risk:  700 677 1116 1123 388 398 104 99 152 149 54 40 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 104 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
120 
disease_progression 
H-positive risk:  676 700 100 1126 395 103 1117 389 148 42 151 53 
H-negative risk:  700 676 1117 1126 389 395 103 100 151 148 53 42 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 102 17 

clinical_engagement 
diagnosis 
demography 
60 new agents 
121 
disease_progression 
H-positive risk:  645 655 97 1169 388 99 1149 397 153 43 153 52 
H-negative risk:  655 645 1149 1169 397 388 99 97 153 153 52 43 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 101 21 

clinical_engagement 
diagnosis 
demography 
104 new agents 
122 
disease_progression 
H-positive risk:  637 654 97 1155 405 100 1148 401 154 45 154 50 
H-negative risk:  654 637 1148 1155 401 405 100 97 154 154 50 45 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 102 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
123 
disease_progression 
H-positive risk:  637 656 92 1153 405 103 1156 395 151 46 155 51 
H-negative risk:  656 637 1156 1153 395 405 103 92 155 151 51 46 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 103 20 

clinical_engagement 
diagnosis 
demography 
92 new agents 
124 
disease_progression 
H-positive risk:  647 664 93 1139 397 104 1158 395 148 45 156 54 
H-negative risk:  664 647 1158 1139 395 397 104 93 156 148 54 45 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 102 19 

clinical_engagement 
diagnosis 
demography 
96 new agents 
125 
disease_progression 
H-positive risk:  654 671 93 1137 389 105 1160 392 147 44 155 53 
H-negative risk:  671 654 1160 1137 392 389 105 93 155 147 53 44 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 101 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
126 
disease_progression 
H-positive risk:  652 675 93 1134 394 105 1158 391 148 40 158 52 
H-negative risk:  675 652 1158 1134 391 394 105 93 158 148 52 40 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 102 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
127 
disease_progression 
H-positive risk:  646 672 94 1140 393 107 1158 392 150 40 153 55 
H-negative risk:  672 646 1158 1140 392 393 107 94 153 150 55 40 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 102 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
128 
disease_progression 
H-positive risk:  654 672 95 1129 396 108 1157 394 150 40 151 54 
H-negative risk:  672 654 1157 1129 394 396 108 95 151 150 54 40 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 102 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
129 
disease_progression 
H-positive risk:  654 671 97 1135 399 107 1157 389 148 39 154 50 
H-negative risk:  671 654 1157 1135 389 399 107 97 154 148 50 39 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 102 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
130 
disease_progression 
H-positive risk:  654 668 97 1146 392 107 1150 389 154 40 152 51 
H-negative risk:  668 654 1150 1146 389 392 107 97 152 154 51 40 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 101 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
131 
disease_progression 
H-positive risk:  645 672 95 1147 389 106 1159 393 153 39 150 52 
H-negative risk:  672 645 1159 1147 393 389 106 95 150 153 52 39 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 96 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
132 
disease_progression 
H-positive risk:  650 664 96 1154 378 107 1165 392 154 38 152 50 
H-negative risk:  664 650 1165 1154 392 378 107 96 152 154 50 38 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 97 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
133 
disease_progression 
H-positive risk:  657 662 96 1147 376 102 1167 387 159 40 156 51 
H-negative risk:  662 657 1167 1147 387 376 102 96 156 159 51 40 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
91 new agents 
134 
disease_progression 
H-positive risk:  649 654 97 1141 378 105 1172 391 156 43 156 58 
H-negative risk:  654 649 1172 1141 391 378 105 97 156 156 58 43 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
135 
disease_progression 
H-positive risk:  660 653 99 1139 385 106 1164 382 156 46 151 59 
H-negative risk:  653 660 1164 1139 382 385 106 99 151 156 59 46 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
136 
disease_progression 
H-positive risk:  658 650 100 1153 378 104 1155 389 154 50 149 60 
H-negative risk:  650 658 1155 1153 389 378 104 100 149 154 60 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 93 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
137 
disease_progression 
H-positive risk:  663 649 102 1146 385 104 1147 392 154 53 151 54 
H-negative risk:  649 663 1147 1146 392 385 104 102 151 154 54 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
138 
disease_progression 
H-positive risk:  662 638 105 1154 380 105 1147 394 155 54 153 53 
H-negative risk:  638 662 1147 1154 394 380 105 105 153 155 53 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
139 
disease_progression 
H-positive risk:  669 639 104 1146 387 106 1137 394 158 56 152 52 
H-negative risk:  639 669 1137 1146 394 387 106 104 152 158 52 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
140 
disease_progression 
H-positive risk:  670 641 107 1144 382 104 1131 399 154 58 157 53 
H-negative risk:  641 670 1131 1144 399 382 104 107 157 154 53 58 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
141 
disease_progression 
H-positive risk:  666 638 105 1157 384 100 1137 388 158 57 157 53 
H-negative risk:  638 666 1137 1157 388 384 100 105 157 158 53 57 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
142 
disease_progression 
H-positive risk:  665 630 102 1165 391 101 1139 378 159 58 157 55 
H-negative risk:  630 665 1139 1165 378 391 101 102 157 159 55 58 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
143 
disease_progression 
H-positive risk:  667 631 103 1167 390 101 1136 379 159 59 156 52 
H-negative risk:  631 667 1136 1167 379 390 101 103 156 159 52 59 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 98 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
144 
disease_progression 
H-positive risk:  670 638 103 1171 383 105 1134 373 155 58 158 52 
H-negative risk:  638 670 1134 1171 373 383 105 103 158 155 52 58 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 98 20 

clinical_engagement 
diagnosis 
demography 
105 new agents 
145 
disease_progression 
H-positive risk:  678 644 105 1166 381 107 1128 369 156 58 159 49 
H-negative risk:  644 678 1128 1166 369 381 107 105 159 156 49 58 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 96 18 

clinical_engagement 
diagnosis 
demography 
90 new agents 
146 
disease_progression 
H-positive risk:  675 643 107 1155 398 108 1109 386 153 57 159 50 
H-negative risk:  643 675 1109 1155 386 398 108 107 159 153 50 57 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 99 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
147 
disease_progression 
H-positive risk:  673 642 107 1158 404 107 1108 381 155 56 159 50 
H-negative risk:  642 673 1108 1158 381 404 107 107 159 155 50 56 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 102 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
148 
disease_progression 
H-positive risk:  675 637 109 1168 405 106 1105 382 153 55 155 50 
H-negative risk:  637 675 1105 1168 382 405 106 109 155 153 50 55 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 101 17 

clinical_engagement 
diagnosis 
demography 
80 new agents 
149 
disease_progression 
H-positive risk:  678 642 109 1167 400 105 1108 378 153 54 156 50 
H-negative risk:  642 678 1108 1167 378 400 105 109 156 153 50 54 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 102 17 

clinical_engagement 
diagnosis 
demography 
89 new agents 
150 
disease_progression 
H-positive risk:  679 644 111 1169 399 107 1104 380 153 51 154 49 
H-negative risk:  644 679 1104 1169 380 399 107 111 154 153 49 51 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 100 19 

clinical_engagement 
diagnosis 
demography 
62 new agents 
151 
disease_progression 
H-positive risk:  679 645 110 1169 403 107 1103 377 154 50 154 49 
H-negative risk:  645 679 1103 1169 377 403 107 110 154 154 49 50 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 102 19 

clinical_engagement 
diagnosis 
demography 
84 new agents 
152 
disease_progression 
H-positive risk:  675 640 115 1170 400 107 1107 379 150 50 155 52 
H-negative risk:  640 675 1107 1170 379 400 107 115 155 150 52 50 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 101 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
153 
disease_progression 
H-positive risk:  675 644 114 1171 399 109 1094 383 151 51 155 54 
H-negative risk:  644 675 1094 1171 383 399 109 114 155 151 54 51 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 103 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
154 
disease_progression 
H-positive risk:  670 642 114 1177 400 107 1097 382 153 49 152 57 
H-negative risk:  642 670 1097 1177 382 400 107 114 152 153 57 49 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 103 18 

clinical_engagement 
diagnosis 
demography 
92 new agents 
155 
disease_progression 
H-positive risk:  665 645 115 1179 401 109 1103 375 155 49 153 51 
H-negative risk:  645 665 1103 1179 375 401 109 115 153 155 51 49 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 104 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
156 
disease_progression 
H-positive risk:  669 647 117 1182 399 107 1095 375 153 50 152 54 
H-negative risk:  647 669 1095 1182 375 399 107 117 152 153 54 50 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 105 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
157 
disease_progression 
H-positive risk:  663 654 116 1186 393 110 1096 370 154 52 151 55 
H-negative risk:  654 663 1096 1186 370 393 110 116 151 154 55 52 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 105 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
158 
disease_progression 
H-positive risk:  668 652 116 1170 403 110 1086 382 152 54 154 53 
H-negative risk:  652 668 1086 1170 382 403 110 116 154 152 53 54 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 105 20 

clinical_engagement 
diagnosis 
demography 
59 new agents 
159 
disease_progression 
H-positive risk:  671 647 113 1170 402 112 1081 387 155 53 155 54 
H-negative risk:  647 671 1081 1170 387 402 112 113 155 155 54 53 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 105 23 

clinical_engagement 
diagnosis 
demography 
60 new agents 
160 
disease_progression 
H-positive risk:  668 647 115 1181 396 113 1076 387 154 55 156 52 
H-negative risk:  647 668 1076 1181 387 396 113 115 156 154 52 55 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 105 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
161 
disease_progression 
H-positive risk:  663 650 115 1169 400 112 1081 390 158 52 156 54 
H-negative risk:  650 663 1081 1169 390 400 112 115 156 158 54 52 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 104 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
162 
disease_progression 
H-positive risk:  663 655 118 1175 389 111 1079 387 159 54 157 53 
H-negative risk:  655 663 1079 1175 387 389 111 118 157 159 53 54 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 102 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
163 
disease_progression 
H-positive risk:  662 653 120 1164 394 110 1081 389 160 55 157 55 
H-negative risk:  653 662 1081 1164 389 394 110 120 157 160 55 55 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 100 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
164 
disease_progression 
H-positive risk:  661 660 117 1170 394 112 1073 383 159 56 162 53 
H-negative risk:  660 661 1073 1170 383 394 112 117 162 159 53 56 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 100 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
165 
disease_progression 
H-positive risk:  666 663 118 1169 390 114 1073 385 152 58 158 54 
H-negative risk:  663 666 1073 1169 385 390 114 118 158 152 54 58 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 100 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
166 
disease_progression 
H-positive risk:  665 662 113 1156 390 114 1088 380 156 59 164 53 
H-negative risk:  662 665 1088 1156 380 390 114 113 164 156 53 59 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 101 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
167 
disease_progression 
H-positive risk:  667 656 115 1158 395 117 1085 380 157 58 160 52 
H-negative risk:  656 667 1085 1158 380 395 117 115 160 157 52 58 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 104 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
168 
disease_progression 
H-positive risk:  671 659 113 1159 398 114 1073 382 158 60 157 56 
H-negative risk:  659 671 1073 1159 382 398 114 113 157 158 56 60 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 102 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
169 
disease_progression 
H-positive risk:  667 665 111 1152 394 113 1083 383 159 60 156 57 
H-negative risk:  665 667 1083 1152 383 394 113 111 156 159 57 60 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 102 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
170 
disease_progression 
H-positive risk:  657 665 111 1150 407 112 1073 387 161 60 157 60 
H-negative risk:  665 657 1073 1150 387 407 112 111 157 161 60 60 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 106 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
171 
disease_progression 
H-positive risk:  663 664 110 1145 417 110 1061 388 165 60 157 60 
H-negative risk:  664 663 1061 1145 388 417 110 110 157 165 60 60 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 107 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
172 
disease_progression 
H-positive risk:  670 661 107 1145 419 111 1052 385 169 60 160 61 
H-negative risk:  661 670 1052 1145 385 419 111 107 160 169 61 60 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 105 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
173 
disease_progression 
H-positive risk:  669 665 107 1140 423 111 1058 387 164 58 158 60 
H-negative risk:  665 669 1058 1140 387 423 111 107 158 164 60 58 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 104 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
174 
disease_progression 
H-positive risk:  669 665 104 1141 418 108 1069 384 167 57 160 58 
H-negative risk:  665 669 1069 1141 384 418 108 104 160 167 58 57 
New BC onsets:  135
BC status:  4865 135 
BC subtype:  4865 108 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
175 
disease_progression 
H-positive risk:  658 667 104 1134 418 107 1067 391 171 60 165 58 
H-negative risk:  667 658 1067 1134 391 418 107 104 165 171 58 60 
New BC onsets:  140
BC status:  4860 140 
BC subtype:  4860 112 28 

clinical_engagement 
diagnosis 
demography 
64 new agents 
176 
disease_progression 
H-positive risk:  651 665 106 1136 415 110 1066 396 172 60 165 58 
H-negative risk:  665 651 1066 1136 396 415 110 106 165 172 58 60 
New BC onsets:  139
BC status:  4861 139 
BC subtype:  4861 111 28 

clinical_engagement 
diagnosis 
demography 
66 new agents 
177 
disease_progression 
H-positive risk:  659 663 104 1133 412 110 1064 400 171 60 162 62 
H-negative risk:  663 659 1064 1133 400 412 110 104 162 171 62 60 
New BC onsets:  142
BC status:  4858 142 
BC subtype:  4858 111 31 

clinical_engagement 
diagnosis 
demography 
80 new agents 
178 
disease_progression 
H-positive risk:  654 660 104 1133 415 111 1074 397 171 60 161 60 
H-negative risk:  660 654 1074 1133 397 415 111 104 161 171 60 60 
New BC onsets:  139
BC status:  4861 139 
BC subtype:  4861 109 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
179 
disease_progression 
H-positive risk:  649 656 104 1133 413 111 1083 397 174 61 161 58 
H-negative risk:  656 649 1083 1133 397 413 111 104 161 174 58 61 
New BC onsets:  133
BC status:  4867 133 
BC subtype:  4867 102 31 

clinical_engagement 
diagnosis 
demography 
74 new agents 
180 
disease_progression 
H-positive risk:  648 656 103 1120 414 110 1090 399 174 63 163 60 
H-negative risk:  656 648 1090 1120 399 414 110 103 163 174 60 63 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 100 29 

clinical_engagement 
diagnosis 
demography 
81 new agents 
181 
disease_progression 
H-positive risk:  644 654 101 1119 424 108 1093 398 176 61 165 57 
H-negative risk:  654 644 1093 1119 398 424 108 101 165 176 57 61 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 101 30 

clinical_engagement 
diagnosis 
demography 
102 new agents 
182 
disease_progression 
H-positive risk:  649 659 99 1104 427 110 1091 402 173 58 167 61 
H-negative risk:  659 649 1091 1104 402 427 110 99 167 173 61 58 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 102 30 

clinical_engagement 
diagnosis 
demography 
89 new agents 
183 
disease_progression 
H-positive risk:  641 665 100 1105 424 110 1095 400 171 57 172 60 
H-negative risk:  665 641 1095 1105 400 424 110 100 172 171 60 57 
New BC onsets:  136
BC status:  4864 136 
BC subtype:  4864 105 31 

clinical_engagement 
diagnosis 
demography 
84 new agents 
184 
disease_progression 
H-positive risk:  646 669 100 1114 414 109 1094 393 169 56 174 62 
H-negative risk:  669 646 1094 1114 393 414 109 100 174 169 62 56 
New BC onsets:  135
BC status:  4865 135 
BC subtype:  4865 104 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
185 
disease_progression 
H-positive risk:  651 667 100 1098 429 108 1086 397 171 52 178 63 
H-negative risk:  667 651 1086 1098 397 429 108 100 178 171 63 52 
New BC onsets:  138
BC status:  4862 138 
BC subtype:  4862 109 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
186 
disease_progression 
H-positive risk:  653 657 101 1107 427 108 1088 398 169 51 178 63 
H-negative risk:  657 653 1088 1107 398 427 108 101 178 169 63 51 
New BC onsets:  138
BC status:  4862 138 
BC subtype:  4862 108 30 

clinical_engagement 
diagnosis 
demography 
65 new agents 
187 
disease_progression 
H-positive risk:  645 658 99 1102 433 106 1095 402 170 51 177 62 
H-negative risk:  658 645 1095 1102 402 433 106 99 177 170 62 51 
New BC onsets:  136
BC status:  4864 136 
BC subtype:  4864 106 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
188 
disease_progression 
H-positive risk:  646 658 101 1103 431 103 1096 404 172 51 177 58 
H-negative risk:  658 646 1096 1103 404 431 103 101 177 172 58 51 
New BC onsets:  134
BC status:  4866 134 
BC subtype:  4866 105 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
189 
disease_progression 
H-positive risk:  642 665 102 1099 432 104 1094 405 171 49 177 60 
H-negative risk:  665 642 1094 1099 405 432 104 102 177 171 60 49 
New BC onsets:  135
BC status:  4865 135 
BC subtype:  4865 106 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
190 
disease_progression 
H-positive risk:  642 669 101 1107 427 102 1091 403 171 50 176 61 
H-negative risk:  669 642 1091 1107 403 427 102 101 176 171 61 50 
New BC onsets:  138
BC status:  4862 138 
BC subtype:  4862 106 32 

clinical_engagement 
diagnosis 
demography 
84 new agents 
191 
disease_progression 
H-positive risk:  643 674 102 1107 427 103 1080 406 169 54 175 60 
H-negative risk:  674 643 1080 1107 406 427 103 102 175 169 60 54 
New BC onsets:  139
BC status:  4861 139 
BC subtype:  4861 107 32 

clinical_engagement 
diagnosis 
demography 
74 new agents 
192 
disease_progression 
H-positive risk:  643 670 100 1113 422 101 1079 410 169 55 175 63 
H-negative risk:  670 643 1079 1113 410 422 101 100 175 169 63 55 
New BC onsets:  138
BC status:  4862 138 
BC subtype:  4862 104 34 

clinical_engagement 
diagnosis 
demography 
84 new agents 
193 
disease_progression 
H-positive risk:  651 668 100 1112 423 99 1069 419 159 59 177 64 
H-negative risk:  668 651 1069 1112 419 423 99 100 177 159 64 59 
New BC onsets:  136
BC status:  4864 136 
BC subtype:  4864 102 34 

clinical_engagement 
diagnosis 
demography 
78 new agents 
194 
disease_progression 
H-positive risk:  655 665 102 1111 422 96 1060 428 159 61 176 65 
H-negative risk:  665 655 1060 1111 428 422 96 102 176 159 65 61 
New BC onsets:  133
BC status:  4867 133 
BC subtype:  4867 99 34 

clinical_engagement 
diagnosis 
demography 
65 new agents 
195 
disease_progression 
H-positive risk:  656 670 101 1104 425 94 1048 440 160 58 179 65 
H-negative risk:  670 656 1048 1104 440 425 94 101 179 160 65 58 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 96 31 

clinical_engagement 
diagnosis 
demography 
85 new agents 
196 
disease_progression 
H-positive risk:  657 673 100 1100 425 96 1050 444 159 59 175 62 
H-negative risk:  673 657 1050 1100 444 425 96 100 175 159 62 59 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 94 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
197 
disease_progression 
H-positive risk:  659 668 102 1106 429 91 1046 442 161 56 175 65 
H-negative risk:  668 659 1046 1106 442 429 91 102 175 161 65 56 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 93 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
198 
disease_progression 
H-positive risk:  668 660 104 1114 433 89 1036 442 165 55 172 62 
H-negative risk:  660 668 1036 1114 442 433 89 104 172 165 62 55 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 88 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
199 
disease_progression 
H-positive risk:  667 664 106 1109 429 89 1044 443 167 54 167 61 
H-negative risk:  664 667 1044 1109 443 429 89 106 167 167 61 54 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 86 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
200 
disease_progression 
H-positive risk:  668 656 107 1115 434 89 1039 442 165 58 166 61 
H-negative risk:  656 668 1039 1115 442 434 89 107 166 165 61 58 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 88 33 

clinical_engagement 
diagnosis 
demography 
75 new agents 
201 
disease_progression 
H-positive risk:  658 653 108 1124 436 85 1047 437 167 58 167 60 
H-negative risk:  653 658 1047 1124 437 436 85 108 167 167 60 58 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 86 35 

clinical_engagement 
diagnosis 
demography 
73 new agents 
202 
disease_progression 
H-positive risk:  661 658 109 1115 440 83 1041 440 168 58 169 58 
H-negative risk:  658 661 1041 1115 440 440 83 109 169 168 58 58 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 89 35 

clinical_engagement 
diagnosis 
demography 
100 new agents 
203 
disease_progression 
H-positive risk:  676 656 112 1116 434 83 1032 437 170 57 171 56 
H-negative risk:  656 676 1032 1116 437 434 83 112 171 170 56 57 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 91 35 

clinical_engagement 
diagnosis 
demography 
73 new agents 
204 
disease_progression 
H-positive risk:  672 657 113 1111 436 83 1033 440 169 58 173 55 
H-negative risk:  657 672 1033 1111 440 436 83 113 173 169 55 58 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 88 36 

clinical_engagement 
diagnosis 
demography 
85 new agents 
205 
disease_progression 
H-positive risk:  669 659 110 1109 442 85 1042 432 169 55 173 55 
H-negative risk:  659 669 1042 1109 432 442 85 110 173 169 55 55 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 87 36 

clinical_engagement 
diagnosis 
demography 
96 new agents 
206 
disease_progression 
H-positive risk:  677 662 110 1089 453 84 1033 436 165 57 173 61 
H-negative risk:  662 677 1033 1089 436 453 84 110 173 165 61 57 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 85 38 

clinical_engagement 
diagnosis 
demography 
96 new agents 
207 
disease_progression 
H-positive risk:  677 665 109 1089 451 84 1043 429 161 59 174 59 
H-negative risk:  665 677 1043 1089 429 451 84 109 174 161 59 59 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 87 37 

clinical_engagement 
diagnosis 
demography 
84 new agents 
208 
disease_progression 
H-positive risk:  674 667 107 1082 458 82 1045 427 163 59 175 61 
H-negative risk:  667 674 1045 1082 427 458 82 107 175 163 61 59 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 84 34 

clinical_engagement 
diagnosis 
demography 
75 new agents 
209 
disease_progression 
H-positive risk:  673 673 107 1083 459 84 1042 427 161 58 172 61 
H-negative risk:  673 673 1042 1083 427 459 84 107 172 161 61 58 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 84 34 

clinical_engagement 
diagnosis 
demography 
60 new agents 
210 
disease_progression 
H-positive risk:  671 670 106 1089 456 84 1051 423 158 60 173 59 
H-negative risk:  670 671 1051 1089 423 456 84 106 173 158 59 60 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 87 33 

clinical_engagement 
diagnosis 
demography 
68 new agents 
211 
disease_progression 
H-positive risk:  672 673 107 1089 450 81 1050 424 159 60 173 62 
H-negative risk:  673 672 1050 1089 424 450 81 107 173 159 62 60 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 86 31 

clinical_engagement 
diagnosis 
demography 
62 new agents 
212 
disease_progression 
H-positive risk:  678 666 106 1097 447 84 1044 425 158 61 172 62 
H-negative risk:  666 678 1044 1097 425 447 84 106 172 158 62 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 87 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
213 
disease_progression 
H-positive risk:  672 671 107 1091 442 82 1062 427 160 59 163 64 
H-negative risk:  671 672 1062 1091 427 442 82 107 163 160 64 59 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 88 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
214 
disease_progression 
H-positive risk:  676 680 107 1080 439 87 1064 427 155 59 164 62 
H-negative risk:  680 676 1064 1080 427 439 87 107 164 155 62 59 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 86 29 

clinical_engagement 
diagnosis 
demography 
60 new agents 
215 
disease_progression 
H-positive risk:  669 676 103 1083 440 86 1075 429 155 58 163 63 
H-negative risk:  676 669 1075 1083 429 440 86 103 163 155 63 58 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 85 33 

clinical_engagement 
diagnosis 
demography 
61 new agents 
216 
disease_progression 
H-positive risk:  670 682 101 1078 437 85 1080 429 153 59 166 60 
H-negative risk:  682 670 1080 1078 429 437 85 101 166 153 60 59 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 85 34 

clinical_engagement 
diagnosis 
demography 
79 new agents 
217 
disease_progression 
H-positive risk:  670 683 102 1073 451 87 1064 440 151 58 159 62 
H-negative risk:  683 670 1064 1073 440 451 87 102 159 151 62 58 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 86 34 

clinical_engagement 
diagnosis 
demography 
86 new agents 
218 
disease_progression 
H-positive risk:  671 680 104 1076 445 87 1069 433 154 59 160 62 
H-negative risk:  680 671 1069 1076 433 445 87 104 160 154 62 59 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 85 34 

clinical_engagement 
diagnosis 
demography 
90 new agents 
219 
disease_progression 
H-positive risk:  670 685 102 1074 446 90 1065 432 156 58 161 61 
H-negative risk:  685 670 1065 1074 432 446 90 102 161 156 61 58 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 84 36 

clinical_engagement 
diagnosis 
demography 
79 new agents 
220 
disease_progression 
H-positive risk:  680 695 100 1069 446 89 1051 440 156 55 159 60 
H-negative risk:  695 680 1051 1069 440 446 89 100 159 156 60 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 81 36 

clinical_engagement 
diagnosis 
demography 
81 new agents 
221 
disease_progression 
H-positive risk:  679 703 100 1070 439 91 1053 436 156 55 160 58 
H-negative risk:  703 679 1053 1070 436 439 91 100 160 156 58 55 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 83 36 

clinical_engagement 
diagnosis 
demography 
78 new agents 
222 
disease_progression 
H-positive risk:  681 710 96 1065 443 93 1061 425 151 58 160 57 
H-negative risk:  710 681 1061 1065 425 443 93 96 160 151 57 58 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 82 36 

clinical_engagement 
diagnosis 
demography 
78 new agents 
223 
disease_progression 
H-positive risk:  679 709 96 1077 440 97 1059 424 151 56 153 59 
H-negative risk:  709 679 1059 1077 424 440 97 96 153 151 59 56 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 82 36 

clinical_engagement 
diagnosis 
demography 
68 new agents 
224 
disease_progression 
H-positive risk:  673 715 94 1081 442 93 1062 421 153 56 153 57 
H-negative risk:  715 673 1062 1081 421 442 93 94 153 153 57 56 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 83 36 

clinical_engagement 
diagnosis 
demography 
73 new agents 
225 
disease_progression 
H-positive risk:  679 718 94 1076 445 94 1066 416 150 55 152 55 
H-negative risk:  718 679 1066 1076 416 445 94 94 152 150 55 55 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 80 36 

clinical_engagement 
diagnosis 
demography 
58 new agents 
226 
disease_progression 
H-positive risk:  677 716 92 1078 450 94 1062 419 149 60 150 53 
H-negative risk:  716 677 1062 1078 419 450 94 92 150 149 53 60 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 83 36 

clinical_engagement 
diagnosis 
demography 
61 new agents 
227 
disease_progression 
H-positive risk:  675 709 91 1078 456 91 1066 419 154 58 149 54 
H-negative risk:  709 675 1066 1078 419 456 91 91 149 154 54 58 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 84 36 

clinical_engagement 
diagnosis 
demography 
74 new agents 
228 
disease_progression 
H-positive risk:  675 707 91 1086 459 90 1061 417 157 54 151 52 
H-negative risk:  707 675 1061 1086 417 459 90 91 151 157 52 54 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 84 37 

clinical_engagement 
diagnosis 
demography 
74 new agents 
229 
disease_progression 
H-positive risk:  677 703 91 1085 459 90 1067 416 155 55 149 53 
H-negative risk:  703 677 1067 1085 416 459 90 91 149 155 53 55 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 81 37 

clinical_engagement 
diagnosis 
demography 
86 new agents 
230 
disease_progression 
H-positive risk:  675 701 89 1087 456 88 1066 417 158 54 154 55 
H-negative risk:  701 675 1066 1087 417 456 88 89 154 158 55 54 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 79 38 

clinical_engagement 
diagnosis 
demography 
85 new agents 
231 
disease_progression 
H-positive risk:  675 697 90 1083 467 86 1059 417 159 55 154 58 
H-negative risk:  697 675 1059 1083 417 467 86 90 154 159 58 55 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 81 38 

clinical_engagement 
diagnosis 
demography 
79 new agents 
232 
disease_progression 
H-positive risk:  675 694 92 1086 462 86 1060 422 157 54 152 60 
H-negative risk:  694 675 1060 1086 422 462 86 92 152 157 60 54 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 81 36 

clinical_engagement 
diagnosis 
demography 
82 new agents 
233 
disease_progression 
H-positive risk:  685 685 86 1093 454 85 1064 416 157 56 157 62 
H-negative risk:  685 685 1064 1093 416 454 85 86 157 157 62 56 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 80 36 

clinical_engagement 
diagnosis 
demography 
80 new agents 
234 
disease_progression 
H-positive risk:  693 683 82 1087 458 82 1066 415 155 55 162 62 
H-negative risk:  683 693 1066 1087 415 458 82 82 162 155 62 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 82 35 

clinical_engagement 
diagnosis 
demography 
74 new agents 
235 
disease_progression 
H-positive risk:  693 683 78 1092 453 78 1066 416 159 54 166 62 
H-negative risk:  683 693 1066 1092 416 453 78 78 166 159 62 54 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 85 34 

clinical_engagement 
diagnosis 
demography 
74 new agents 
236 
disease_progression 
H-positive risk:  697 686 72 1092 448 76 1065 415 160 57 171 61 
H-negative risk:  686 697 1065 1092 415 448 76 72 171 160 61 57 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 87 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
237 
disease_progression 
H-positive risk:  700 690 72 1099 445 79 1066 405 156 57 172 59 
H-negative risk:  690 700 1066 1099 405 445 79 72 172 156 59 57 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 87 33 

clinical_engagement 
diagnosis 
demography 
75 new agents 
238 
disease_progression 
H-positive risk:  697 687 71 1105 441 82 1054 418 157 56 170 62 
H-negative risk:  687 697 1054 1105 418 441 82 71 170 157 62 56 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 91 33 

clinical_engagement 
diagnosis 
demography 
68 new agents 
239 
disease_progression 
H-positive risk:  700 689 71 1104 441 80 1059 415 157 58 167 59 
H-negative risk:  689 700 1059 1104 415 441 80 71 167 157 59 58 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 93 32 

clinical_engagement 
diagnosis 
demography 
80 new agents 
240 
disease_progression 
H-positive risk:  704 689 71 1108 439 81 1058 408 158 60 166 58 
H-negative risk:  689 704 1058 1108 408 439 81 71 166 158 58 60 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 94 32 

clinical_engagement 
diagnosis 
demography 
70 new agents 
241 
disease_progression 
H-positive risk:  706 684 73 1103 441 81 1053 417 159 61 162 60 
H-negative risk:  684 706 1053 1103 417 441 81 73 162 159 60 61 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 92 30 

clinical_engagement 
diagnosis 
demography 
93 new agents 
242 
disease_progression 
H-positive risk:  695 680 72 1109 444 80 1061 410 163 61 163 62 
H-negative risk:  680 695 1061 1109 410 444 80 72 163 163 62 61 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 90 29 

clinical_engagement 
diagnosis 
demography 
81 new agents 
243 
disease_progression 
H-positive risk:  693 678 71 1105 446 82 1062 414 161 59 168 61 
H-negative risk:  678 693 1062 1105 414 446 82 71 168 161 61 59 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 90 29 

clinical_engagement 
diagnosis 
demography 
89 new agents 
244 
disease_progression 
H-positive risk:  690 683 70 1102 430 81 1068 423 166 59 168 60 
H-negative risk:  683 690 1068 1102 423 430 81 70 168 166 60 59 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 87 31 

clinical_engagement 
diagnosis 
demography 
96 new agents 
245 
disease_progression 
H-positive risk:  690 684 73 1097 423 82 1079 421 164 60 169 58 
H-negative risk:  684 690 1079 1097 421 423 82 73 169 164 58 60 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 88 30 

clinical_engagement 
diagnosis 
demography 
84 new agents 
246 
disease_progression 
H-positive risk:  691 685 72 1102 423 85 1079 414 160 62 169 58 
H-negative risk:  685 691 1079 1102 414 423 85 72 169 160 58 62 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 86 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
247 
disease_progression 
H-positive risk:  688 690 77 1102 424 84 1079 409 160 62 168 57 
H-negative risk:  690 688 1079 1102 409 424 84 77 168 160 57 62 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 81 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
248 
disease_progression 
H-positive risk:  691 680 78 1099 423 84 1075 420 163 62 168 57 
H-negative risk:  680 691 1075 1099 420 423 84 78 168 163 57 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
249 
disease_progression 
H-positive risk:  687 673 77 1102 430 85 1078 425 163 60 167 53 
H-negative risk:  673 687 1078 1102 425 430 85 77 167 163 53 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 77 30 

clinical_engagement 
diagnosis 
demography 
66 new agents 
250 
disease_progression 
H-positive risk:  687 665 78 1099 437 85 1077 428 165 60 166 53 
H-negative risk:  665 687 1077 1099 428 437 85 78 166 165 53 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 76 33 

clinical_engagement 
diagnosis 
demography 
66 new agents 
251 
disease_progression 
H-positive risk:  681 668 75 1101 443 85 1082 425 160 62 168 50 
H-negative risk:  668 681 1082 1101 425 443 85 75 168 160 50 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
76 new agents 
252 
disease_progression 
H-positive risk:  684 661 78 1109 451 85 1073 424 158 64 166 47 
H-negative risk:  661 684 1073 1109 424 451 85 78 166 158 47 64 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 80 31 

clinical_engagement 
diagnosis 
demography 
83 new agents 
253 
disease_progression 
H-positive risk:  692 661 77 1118 440 84 1077 420 156 62 167 46 
H-negative risk:  661 692 1077 1118 420 440 84 77 167 156 46 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 79 31 

clinical_engagement 
diagnosis 
demography 
89 new agents 
254 
disease_progression 
H-positive risk:  692 664 79 1117 439 81 1088 412 154 64 163 47 
H-negative risk:  664 692 1088 1117 412 439 81 79 163 154 47 64 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 80 31 

clinical_engagement 
diagnosis 
demography 
75 new agents 
255 
disease_progression 
H-positive risk:  692 664 76 1113 436 81 1089 418 152 63 166 50 
H-negative risk:  664 692 1089 1113 418 436 81 76 166 152 50 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 82 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
256 
disease_progression 
H-positive risk:  682 656 76 1117 436 80 1098 420 153 64 167 51 
H-negative risk:  656 682 1098 1117 420 436 80 76 167 153 51 64 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
73 new agents 
257 
disease_progression 
H-positive risk:  687 662 75 1109 440 77 1099 411 156 64 169 51 
H-negative risk:  662 687 1099 1109 411 440 77 75 169 156 51 64 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 85 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
258 
disease_progression 
H-positive risk:  685 669 77 1107 437 77 1102 413 157 57 165 54 
H-negative risk:  669 685 1102 1107 413 437 77 77 165 157 54 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
65 new agents 
259 
disease_progression 
H-positive risk:  686 663 76 1106 442 78 1108 413 154 57 163 54 
H-negative risk:  663 686 1108 1106 413 442 78 76 163 154 54 57 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 86 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
260 
disease_progression 
H-positive risk:  682 666 78 1101 439 79 1114 419 152 57 161 52 
H-negative risk:  666 682 1114 1101 419 439 79 78 161 152 52 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
261 
disease_progression 
H-positive risk:  674 674 78 1105 434 77 1107 427 152 56 162 54 
H-negative risk:  674 674 1107 1105 427 434 77 78 162 152 54 56 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 94 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
262 
disease_progression 
H-positive risk:  673 679 80 1098 435 77 1118 418 154 53 160 55 
H-negative risk:  679 673 1118 1098 418 435 77 80 160 154 55 53 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 94 27 

clinical_engagement 
diagnosis 
demography 
99 new agents 
263 
disease_progression 
H-positive risk:  674 687 81 1092 433 80 1116 415 154 52 161 55 
H-negative risk:  687 674 1116 1092 415 433 80 81 161 154 55 52 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 99 27 

clinical_engagement 
diagnosis 
demography 
68 new agents 
264 
disease_progression 
H-positive risk:  668 695 81 1085 434 81 1127 412 152 50 161 54 
H-negative risk:  695 668 1127 1085 412 434 81 81 161 152 54 50 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 96 28 

clinical_engagement 
diagnosis 
demography 
63 new agents 
265 
disease_progression 
H-positive risk:  654 687 82 1091 438 82 1136 416 148 51 160 55 
H-negative risk:  687 654 1136 1091 416 438 82 82 160 148 55 51 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 99 29 

clinical_engagement 
diagnosis 
demography 
95 new agents 
266 
disease_progression 
H-positive risk:  655 690 82 1104 425 82 1133 415 142 53 162 57 
H-negative risk:  690 655 1133 1104 415 425 82 82 162 142 57 53 
New BC onsets:  134
BC status:  4866 134 
BC subtype:  4866 105 29 

clinical_engagement 
diagnosis 
demography 
71 new agents 
267 
disease_progression 
H-positive risk:  655 688 85 1102 428 85 1128 416 141 55 157 60 
H-negative risk:  688 655 1128 1102 416 428 85 85 157 141 60 55 
New BC onsets:  133
BC status:  4867 133 
BC subtype:  4867 104 29 

clinical_engagement 
diagnosis 
demography 
84 new agents 
268 
disease_progression 
H-positive risk:  652 682 83 1107 430 85 1142 411 136 56 152 64 
H-negative risk:  682 652 1142 1107 411 430 85 83 152 136 64 56 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 102 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
269 
disease_progression 
H-positive risk:  651 686 83 1102 430 84 1153 406 134 56 153 62 
H-negative risk:  686 651 1153 1102 406 430 84 83 153 134 62 56 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 101 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
270 
disease_progression 
H-positive risk:  653 689 83 1101 427 87 1154 403 135 55 153 60 
H-negative risk:  689 653 1154 1101 403 427 87 83 153 135 60 55 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 97 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
271 
disease_progression 
H-positive risk:  653 699 80 1089 439 86 1136 406 135 57 158 62 
H-negative risk:  699 653 1136 1089 406 439 86 80 158 135 62 57 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 95 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
272 
disease_progression 
H-positive risk:  661 701 76 1091 451 86 1128 398 134 55 158 61 
H-negative risk:  701 661 1128 1091 398 451 86 76 158 134 61 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
273 
disease_progression 
H-positive risk:  667 692 79 1096 444 86 1132 405 129 55 155 60 
H-negative risk:  692 667 1132 1096 405 444 86 79 155 129 60 55 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 95 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
274 
disease_progression 
H-positive risk:  677 692 80 1096 440 83 1124 410 130 54 154 60 
H-negative risk:  692 677 1124 1096 410 440 83 80 154 130 60 54 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 92 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
275 
disease_progression 
H-positive risk:  676 697 81 1084 446 83 1125 407 132 54 157 58 
H-negative risk:  697 676 1125 1084 407 446 83 81 157 132 58 54 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
276 
disease_progression 
H-positive risk:  677 704 80 1083 440 82 1116 414 135 53 161 55 
H-negative risk:  704 677 1116 1083 414 440 82 80 161 135 55 53 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
277 
disease_progression 
H-positive risk:  674 698 79 1089 445 82 1108 415 140 52 163 55 
H-negative risk:  698 674 1108 1089 415 445 82 79 163 140 55 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
278 
disease_progression 
H-positive risk:  667 696 80 1097 438 82 1115 418 140 51 164 52 
H-negative risk:  696 667 1115 1097 418 438 82 80 164 140 52 51 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
279 
disease_progression 
H-positive risk:  673 697 80 1096 444 81 1108 415 138 50 162 56 
H-negative risk:  697 673 1108 1096 415 444 81 80 162 138 56 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
90 new agents 
280 
disease_progression 
H-positive risk:  669 702 79 1096 447 87 1102 417 134 49 162 56 
H-negative risk:  702 669 1102 1096 417 447 87 79 162 134 56 49 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
281 
disease_progression 
H-positive risk:  658 705 81 1088 441 86 1111 420 132 53 167 58 
H-negative risk:  705 658 1111 1088 420 441 86 81 167 132 58 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
282 
disease_progression 
H-positive risk:  654 701 83 1086 437 85 1119 421 132 55 169 58 
H-negative risk:  701 654 1119 1086 421 437 85 83 169 132 58 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
283 
disease_progression 
H-positive risk:  654 706 85 1089 435 86 1113 416 136 54 171 55 
H-negative risk:  706 654 1113 1089 416 435 86 85 171 136 55 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
92 new agents 
284 
disease_progression 
H-positive risk:  655 715 86 1086 434 86 1116 413 133 52 173 51 
H-negative risk:  715 655 1116 1086 413 434 86 86 173 133 51 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
90 new agents 
285 
disease_progression 
H-positive risk:  651 721 83 1078 434 87 1119 414 135 55 174 49 
H-negative risk:  721 651 1119 1078 414 434 87 83 174 135 49 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
286 
disease_progression 
H-positive risk:  650 715 87 1083 432 86 1118 415 138 53 173 50 
H-negative risk:  715 650 1118 1083 415 432 86 87 173 138 50 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
287 
disease_progression 
H-positive risk:  651 710 85 1087 435 87 1112 419 139 52 171 52 
H-negative risk:  710 651 1112 1087 419 435 87 85 171 139 52 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
98 new agents 
288 
disease_progression 
H-positive risk:  654 711 86 1087 430 89 1118 412 139 52 168 54 
H-negative risk:  711 654 1118 1087 412 430 89 86 168 139 54 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
289 
disease_progression 
H-positive risk:  657 705 86 1089 426 90 1121 410 140 51 171 54 
H-negative risk:  705 657 1121 1089 410 426 90 86 171 140 54 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
96 new agents 
290 
disease_progression 
H-positive risk:  654 702 85 1081 420 92 1135 407 141 53 176 54 
H-negative risk:  702 654 1135 1081 407 420 92 85 176 141 54 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
291 
disease_progression 
H-positive risk:  659 693 85 1077 425 94 1138 407 140 53 172 57 
H-negative risk:  693 659 1138 1077 407 425 94 85 172 140 57 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
292 
disease_progression 
H-positive risk:  664 692 87 1079 420 94 1129 408 139 56 174 58 
H-negative risk:  692 664 1129 1079 408 420 94 87 174 139 58 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
293 
disease_progression 
H-positive risk:  659 698 83 1079 417 92 1125 413 143 54 177 60 
H-negative risk:  698 659 1125 1079 413 417 92 83 177 143 60 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
294 
disease_progression 
H-positive risk:  654 702 84 1075 416 93 1129 413 143 51 175 65 
H-negative risk:  702 654 1129 1075 413 416 93 84 175 143 65 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
61 new agents 
295 
disease_progression 
H-positive risk:  648 694 83 1069 425 95 1129 424 142 51 173 67 
H-negative risk:  694 648 1129 1069 424 425 95 83 173 142 67 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
296 
disease_progression 
H-positive risk:  649 689 82 1066 430 96 1140 417 139 48 173 71 
H-negative risk:  689 649 1140 1066 417 430 96 82 173 139 71 48 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
70 new agents 
297 
disease_progression 
H-positive risk:  651 682 84 1073 436 93 1136 415 138 52 170 70 
H-negative risk:  682 651 1136 1073 415 436 93 84 170 138 70 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
66 new agents 
298 
disease_progression 
H-positive risk:  653 683 81 1075 429 93 1139 418 139 53 168 69 
H-negative risk:  683 653 1139 1075 418 429 93 81 168 139 69 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
299 
disease_progression 
H-positive risk:  647 685 80 1077 429 90 1143 414 142 53 166 74 
H-negative risk:  685 647 1143 1077 414 429 90 80 166 142 74 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
300 
disease_progression 
H-positive risk:  643 685 80 1070 423 89 1152 421 141 54 168 74 
H-negative risk:  685 643 1152 1070 421 423 89 80 168 141 74 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
301 
disease_progression 
H-positive risk:  639 683 78 1070 431 91 1157 416 145 53 164 73 
H-negative risk:  683 639 1157 1070 416 431 91 78 164 145 73 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
302 
disease_progression 
H-positive risk:  638 682 78 1075 434 89 1147 420 144 53 166 74 
H-negative risk:  682 638 1147 1075 420 434 89 78 166 144 74 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
303 
disease_progression 
H-positive risk:  639 675 78 1086 432 88 1139 419 145 56 169 74 
H-negative risk:  675 639 1139 1086 419 432 88 78 169 145 74 56 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
304 
disease_progression 
H-positive risk:  652 664 79 1090 433 90 1134 419 146 54 166 73 
H-negative risk:  664 652 1134 1090 419 433 90 79 166 146 73 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
92 new agents 
305 
disease_progression 
H-positive risk:  653 671 80 1087 432 88 1127 418 148 52 169 75 
H-negative risk:  671 653 1127 1087 418 432 88 80 169 148 75 52 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
306 
disease_progression 
H-positive risk:  653 683 80 1077 425 89 1129 418 148 55 170 73 
H-negative risk:  683 653 1129 1077 418 425 89 80 170 148 73 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
104 new agents 
307 
disease_progression 
H-positive risk:  664 681 82 1080 429 84 1118 414 151 53 171 73 
H-negative risk:  681 664 1118 1080 414 429 84 82 171 151 73 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
308 
disease_progression 
H-positive risk:  661 678 80 1081 433 87 1124 419 148 50 169 70 
H-negative risk:  678 661 1124 1081 419 433 87 80 169 148 70 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
309 
disease_progression 
H-positive risk:  662 678 82 1096 424 89 1114 417 149 50 168 71 
H-negative risk:  678 662 1114 1096 417 424 89 82 168 149 71 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
310 
disease_progression 
H-positive risk:  666 683 81 1095 422 91 1101 425 150 51 163 72 
H-negative risk:  683 666 1101 1095 425 422 91 81 163 150 72 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
311 
disease_progression 
H-positive risk:  661 671 79 1110 420 93 1095 430 148 55 164 74 
H-negative risk:  671 661 1095 1110 430 420 93 79 164 148 74 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
312 
disease_progression 
H-positive risk:  654 672 78 1107 421 91 1096 433 153 54 167 74 
H-negative risk:  672 654 1096 1107 433 421 91 78 167 153 74 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
313 
disease_progression 
H-positive risk:  655 673 78 1103 423 94 1094 432 155 52 169 72 
H-negative risk:  673 655 1094 1103 432 423 94 78 169 155 72 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
314 
disease_progression 
H-positive risk:  655 674 78 1105 424 93 1092 437 154 49 168 71 
H-negative risk:  674 655 1092 1105 437 424 93 78 168 154 71 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
315 
disease_progression 
H-positive risk:  658 672 77 1109 424 95 1088 435 150 54 169 69 
H-negative risk:  672 658 1088 1109 435 424 95 77 169 150 69 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
91 new agents 
316 
disease_progression 
H-positive risk:  657 678 79 1111 422 90 1078 439 157 55 171 63 
H-negative risk:  678 657 1078 1111 439 422 90 79 171 157 63 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
317 
disease_progression 
H-positive risk:  655 672 81 1119 419 94 1074 444 156 57 167 62 
H-negative risk:  672 655 1074 1119 444 419 94 81 167 156 62 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
318 
disease_progression 
H-positive risk:  656 663 87 1119 420 94 1072 447 157 59 166 60 
H-negative risk:  663 656 1072 1119 447 420 94 87 166 157 60 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
319 
disease_progression 
H-positive risk:  658 663 88 1121 416 93 1072 447 155 59 170 58 
H-negative risk:  663 658 1072 1121 447 416 93 88 170 155 58 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
320 
disease_progression 
H-positive risk:  661 672 91 1117 412 91 1068 447 155 60 167 59 
H-negative risk:  672 661 1068 1117 447 412 91 91 167 155 59 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
321 
disease_progression 
H-positive risk:  655 672 93 1112 413 93 1067 452 155 61 168 59 
H-negative risk:  672 655 1067 1112 452 413 93 93 168 155 59 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
93 new agents 
322 
disease_progression 
H-positive risk:  663 670 95 1095 419 95 1063 460 155 63 164 58 
H-negative risk:  670 663 1063 1095 460 419 95 95 164 155 58 63 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
83 new agents 
323 
disease_progression 
H-positive risk:  663 676 94 1091 422 92 1073 451 153 62 163 60 
H-negative risk:  676 663 1073 1091 451 422 92 94 163 153 60 62 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
324 
disease_progression 
H-positive risk:  668 672 94 1094 422 94 1071 448 153 62 159 63 
H-negative risk:  672 668 1071 1094 448 422 94 94 159 153 63 62 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
95 new agents 
325 
disease_progression 
H-positive risk:  672 685 94 1088 425 96 1057 446 156 60 160 61 
H-negative risk:  685 672 1057 1088 446 425 96 94 160 156 61 60 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
326 
disease_progression 
H-positive risk:  665 682 95 1094 427 98 1071 436 152 62 154 64 
H-negative risk:  682 665 1071 1094 436 427 98 95 154 152 64 62 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 71 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
327 
disease_progression 
H-positive risk:  663 681 98 1093 433 97 1071 435 154 59 155 61 
H-negative risk:  681 663 1071 1093 435 433 97 98 155 154 61 59 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 67 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
328 
disease_progression 
H-positive risk:  658 685 98 1092 437 96 1074 435 152 60 153 60 
H-negative risk:  685 658 1074 1092 435 437 96 98 153 152 60 60 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
329 
disease_progression 
H-positive risk:  652 685 98 1086 445 100 1082 430 153 58 152 59 
H-negative risk:  685 652 1082 1086 430 445 100 98 152 153 59 58 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
89 new agents 
330 
disease_progression 
H-positive risk:  652 686 99 1097 440 102 1087 423 155 58 147 54 
H-negative risk:  686 652 1087 1097 423 440 102 99 147 155 54 58 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
92 new agents 
331 
disease_progression 
H-positive risk:  643 693 103 1090 448 101 1083 425 154 59 147 54 
H-negative risk:  693 643 1083 1090 425 448 101 103 147 154 54 59 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
332 
disease_progression 
H-positive risk:  648 687 102 1096 447 100 1086 417 154 59 150 54 
H-negative risk:  687 648 1086 1096 417 447 100 102 150 154 54 59 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
333 
disease_progression 
H-positive risk:  649 697 99 1090 442 100 1084 422 156 60 148 53 
H-negative risk:  697 649 1084 1090 422 442 100 99 148 156 53 60 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
334 
disease_progression 
H-positive risk:  657 700 100 1085 444 99 1079 429 154 59 142 52 
H-negative risk:  700 657 1079 1085 429 444 99 100 142 154 52 59 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
57 new agents 
335 
disease_progression 
H-positive risk:  659 698 99 1090 446 100 1075 428 153 59 142 51 
H-negative risk:  698 659 1075 1090 428 446 100 99 142 153 51 59 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 73 17 

clinical_engagement 
diagnosis 
demography 
81 new agents 
336 
disease_progression 
H-positive risk:  664 698 97 1093 451 98 1068 425 151 59 145 51 
H-negative risk:  698 664 1068 1093 425 451 98 97 145 151 51 59 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 76 17 

clinical_engagement 
diagnosis 
demography 
90 new agents 
337 
disease_progression 
H-positive risk:  657 701 95 1087 451 102 1076 430 151 56 142 52 
H-negative risk:  701 657 1076 1087 430 451 102 95 142 151 52 56 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 78 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
338 
disease_progression 
H-positive risk:  662 704 95 1087 444 100 1076 427 150 58 146 51 
H-negative risk:  704 662 1076 1087 427 444 100 95 146 150 51 58 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 81 16 

clinical_engagement 
diagnosis 
demography 
61 new agents 
339 
disease_progression 
H-positive risk:  661 696 94 1088 445 101 1079 430 148 59 147 52 
H-negative risk:  696 661 1079 1088 430 445 101 94 147 148 52 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
83 new agents 
340 
disease_progression 
H-positive risk:  660 702 97 1090 440 102 1078 426 147 59 146 53 
H-negative risk:  702 660 1078 1090 426 440 102 97 146 147 53 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 87 16 

clinical_engagement 
diagnosis 
demography 
77 new agents 
341 
disease_progression 
H-positive risk:  663 710 97 1085 436 100 1077 424 151 61 144 52 
H-negative risk:  710 663 1077 1085 424 436 100 97 144 151 52 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 89 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
342 
disease_progression 
H-positive risk:  662 718 97 1078 438 100 1077 423 149 62 141 55 
H-negative risk:  718 662 1077 1078 423 438 100 97 141 149 55 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 89 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
343 
disease_progression 
H-positive risk:  664 717 98 1075 444 99 1066 431 147 64 140 55 
H-negative risk:  717 664 1066 1075 431 444 99 98 140 147 55 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
90 new agents 
344 
disease_progression 
H-positive risk:  665 706 99 1088 441 100 1070 426 143 64 141 57 
H-negative risk:  706 665 1070 1088 426 441 100 99 141 143 57 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
345 
disease_progression 
H-positive risk:  664 703 98 1102 434 99 1069 425 141 67 140 58 
H-negative risk:  703 664 1069 1102 425 434 99 98 140 141 58 67 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
346 
disease_progression 
H-positive risk:  667 692 97 1119 434 100 1064 425 139 64 141 58 
H-negative risk:  692 667 1064 1119 425 434 100 97 141 139 58 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
88 new agents 
347 
disease_progression 
H-positive risk:  671 692 96 1128 436 105 1054 418 138 65 138 59 
H-negative risk:  692 671 1054 1128 418 436 105 96 138 138 59 65 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 90 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
348 
disease_progression 
H-positive risk:  676 690 95 1125 428 105 1058 420 141 67 134 61 
H-negative risk:  690 676 1058 1125 420 428 105 95 134 141 61 67 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 92 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
349 
disease_progression 
H-positive risk:  676 694 94 1124 430 105 1053 419 140 69 135 61 
H-negative risk:  694 676 1053 1124 419 430 105 94 135 140 61 69 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
350 
disease_progression 
H-positive risk:  680 695 93 1125 426 105 1057 416 138 69 137 59 
H-negative risk:  695 680 1057 1125 416 426 105 93 137 138 59 69 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 90 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
351 
disease_progression 
H-positive risk:  675 696 94 1124 429 100 1074 406 145 63 135 59 
H-negative risk:  696 675 1074 1124 406 429 100 94 135 145 59 63 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 94 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
352 
disease_progression 
H-positive risk:  674 704 90 1121 422 100 1086 400 143 62 139 59 
H-negative risk:  704 674 1086 1121 400 422 100 90 139 143 59 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 91 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
353 
disease_progression 
H-positive risk:  669 708 89 1127 425 98 1080 406 143 60 133 62 
H-negative risk:  708 669 1080 1127 406 425 98 89 133 143 62 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 90 18 

clinical_engagement 
diagnosis 
demography 
82 new agents 
354 
disease_progression 
H-positive risk:  672 714 92 1126 431 97 1069 405 143 56 133 62 
H-negative risk:  714 672 1069 1126 405 431 97 92 133 143 62 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
355 
disease_progression 
H-positive risk:  674 710 90 1114 433 101 1076 406 144 53 137 62 
H-negative risk:  710 674 1076 1114 406 433 101 90 137 144 62 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
356 
disease_progression 
H-positive risk:  674 715 93 1114 427 101 1075 406 147 53 134 61 
H-negative risk:  715 674 1075 1114 406 427 101 93 134 147 61 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 90 18 

clinical_engagement 
diagnosis 
demography 
66 new agents 
357 
disease_progression 
H-positive risk:  679 714 94 1113 425 101 1071 408 145 55 133 62 
H-negative risk:  714 679 1071 1113 408 425 101 94 133 145 62 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 90 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
358 
disease_progression 
H-positive risk:  673 709 95 1117 423 101 1085 404 145 55 132 61 
H-negative risk:  709 673 1085 1117 404 423 101 95 132 145 61 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 90 17 

clinical_engagement 
diagnosis 
demography 
88 new agents 
359 
disease_progression 
H-positive risk:  677 718 94 1111 421 97 1095 392 147 56 130 62 
H-negative risk:  718 677 1095 1111 392 421 97 94 130 147 62 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 93 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
360 
disease_progression 
H-positive risk:  679 718 98 1111 414 98 1095 395 148 54 129 61 
H-negative risk:  718 679 1095 1111 395 414 98 98 129 148 61 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 94 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
Time difference of 18.86654 mins
This is task 13
date
